Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Identifieur interne : 000F28 ( Ncbi/Checkpoint ); précédent : 000F27; suivant : 000F29Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Auteurs : Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol ; Cristina Sampaio ; Glenn T. Stebbins ; Carl Counsell ; Nir Giladi ; Robert G. Holloway ; Charity G. Moore ; Gregor K. Wenning ; Melvin D. Yahr ; Lisa SeidlSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.
English descriptors
- KwdEn :
- MESH :
Abstract
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilization and acceptance. Progressively higher stages correlate with neuroimaging studies of dopaminergic loss, and high correlations exist between the HY scale and some standardized scales of motor impairment, disability, and quality of life. Weaknesses include the scale's mixing of impairment and disability and its non-linearity. Because the HY scale is weighted heavily toward postural instability as the primary index of disease severity, it does not capture completely impairments or disability from other motor features of PD and gives no information on nonmotor problems. Direct clinimetric testing of the HY scale has been very limited, but the scale fulfills at least some criteria for reliability and validity, especially for the midranges of the scale (Stages 2-4). Although a "modified HY scale" that includes 0.5 increments has been adopted widely, no clinimetric data are available on this adaptation. The Task Force recommends that: (1) the HY scale be used in its original form for demographic presentation of patient groups; (2) when the HY scale is used for group description, medians and ranges should be reported and analysis of changes should use nonparametric methods; (3) in research settings, the HY scale is useful primarily for defining inclusion/exclusion criteria; (4) to retain simplicity, clinicians should "rate what you see" and therefore incorporate comorbidities when assigning a HY stage; and (5) because of the wide usage of the modified HY scale with 0.5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five-point scales should be maintained.
DOI: 10.1002/mds.20213
PubMed: 15372591
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003360
- to stream PubMed, to step Curation: 003360
- to stream PubMed, to step Checkpoint: 003403
- to stream Ncbi, to step Merge: 000F28
- to stream Ncbi, to step Curation: 000F28
Links to Exploration step
pubmed:15372591Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.</title>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="2"><nlm:affiliation>Rush University Medical Center, 1725 W. Harrison Street, Chicago, IL 60612, USA. cgoetz@rush.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Rush University Medical Center, 1725 W. Harrison Street, Chicago, IL 60612</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation><country>Autriche</country>
<placeName><settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T" last="Stebbins">Glenn T. Stebbins</name>
</author>
<author><name sortKey="Counsell, Carl" sort="Counsell, Carl" uniqKey="Counsell C" first="Carl" last="Counsell">Carl Counsell</name>
</author>
<author><name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
</author>
<author><name sortKey="Holloway, Robert G" sort="Holloway, Robert G" uniqKey="Holloway R" first="Robert G" last="Holloway">Robert G. Holloway</name>
</author>
<author><name sortKey="Moore, Charity G" sort="Moore, Charity G" uniqKey="Moore C" first="Charity G" last="Moore">Charity G. Moore</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
</author>
<author><name sortKey="Yahr, Melvin D" sort="Yahr, Melvin D" uniqKey="Yahr M" first="Melvin D" last="Yahr">Melvin D. Yahr</name>
</author>
<author><name sortKey="Seidl, Lisa" sort="Seidl, Lisa" uniqKey="Seidl L" first="Lisa" last="Seidl">Lisa Seidl</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15372591</idno>
<idno type="pmid">15372591</idno>
<idno type="doi">10.1002/mds.20213</idno>
<idno type="wicri:Area/PubMed/Corpus">003360</idno>
<idno type="wicri:Area/PubMed/Curation">003360</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003403</idno>
<idno type="wicri:Area/Ncbi/Merge">000F28</idno>
<idno type="wicri:Area/Ncbi/Curation">000F28</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000F28</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.</title>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="2"><nlm:affiliation>Rush University Medical Center, 1725 W. Harrison Street, Chicago, IL 60612, USA. cgoetz@rush.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Rush University Medical Center, 1725 W. Harrison Street, Chicago, IL 60612</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation><country>Autriche</country>
<placeName><settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T" last="Stebbins">Glenn T. Stebbins</name>
</author>
<author><name sortKey="Counsell, Carl" sort="Counsell, Carl" uniqKey="Counsell C" first="Carl" last="Counsell">Carl Counsell</name>
</author>
<author><name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
</author>
<author><name sortKey="Holloway, Robert G" sort="Holloway, Robert G" uniqKey="Holloway R" first="Robert G" last="Holloway">Robert G. Holloway</name>
</author>
<author><name sortKey="Moore, Charity G" sort="Moore, Charity G" uniqKey="Moore C" first="Charity G" last="Moore">Charity G. Moore</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
</author>
<author><name sortKey="Yahr, Melvin D" sort="Yahr, Melvin D" uniqKey="Yahr M" first="Melvin D" last="Yahr">Melvin D. Yahr</name>
</author>
<author><name sortKey="Seidl, Lisa" sort="Seidl, Lisa" uniqKey="Seidl L" first="Lisa" last="Seidl">Lisa Seidl</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Feasibility Studies</term>
<term>Health Status</term>
<term>History, 20th Century</term>
<term>Movement Disorders (diagnosis)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Questionnaires</term>
<term>Reproducibility of Results</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Feasibility Studies</term>
<term>Health Status</term>
<term>History, 20th Century</term>
<term>Questionnaires</term>
<term>Reproducibility of Results</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilization and acceptance. Progressively higher stages correlate with neuroimaging studies of dopaminergic loss, and high correlations exist between the HY scale and some standardized scales of motor impairment, disability, and quality of life. Weaknesses include the scale's mixing of impairment and disability and its non-linearity. Because the HY scale is weighted heavily toward postural instability as the primary index of disease severity, it does not capture completely impairments or disability from other motor features of PD and gives no information on nonmotor problems. Direct clinimetric testing of the HY scale has been very limited, but the scale fulfills at least some criteria for reliability and validity, especially for the midranges of the scale (Stages 2-4). Although a "modified HY scale" that includes 0.5 increments has been adopted widely, no clinimetric data are available on this adaptation. The Task Force recommends that: (1) the HY scale be used in its original form for demographic presentation of patient groups; (2) when the HY scale is used for group description, medians and ranges should be reported and analysis of changes should use nonparametric methods; (3) in research settings, the HY scale is useful primarily for defining inclusion/exclusion criteria; (4) to retain simplicity, clinicians should "rate what you see" and therefore incorporate comorbidities when assigning a HY stage; and (5) because of the wide usage of the modified HY scale with 0.5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five-point scales should be maintained.</div>
</front>
</TEI>
<affiliations><list><country><li>Autriche</li>
<li>États-Unis</li>
</country>
<region><li>Illinois</li>
<li>Tyrol (Land)</li>
</region>
<settlement><li>Innsbruck</li>
</settlement>
<orgName><li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Counsell, Carl" sort="Counsell, Carl" uniqKey="Counsell C" first="Carl" last="Counsell">Carl Counsell</name>
<name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
<name sortKey="Holloway, Robert G" sort="Holloway, Robert G" uniqKey="Holloway R" first="Robert G" last="Holloway">Robert G. Holloway</name>
<name sortKey="Moore, Charity G" sort="Moore, Charity G" uniqKey="Moore C" first="Charity G" last="Moore">Charity G. Moore</name>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<name sortKey="Seidl, Lisa" sort="Seidl, Lisa" uniqKey="Seidl L" first="Lisa" last="Seidl">Lisa Seidl</name>
<name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T" last="Stebbins">Glenn T. Stebbins</name>
<name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
<name sortKey="Yahr, Melvin D" sort="Yahr, Melvin D" uniqKey="Yahr M" first="Melvin D" last="Yahr">Melvin D. Yahr</name>
</noCountry>
<country name="États-Unis"><region name="Illinois"><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name>
</region>
</country>
<country name="Autriche"><region name="Tyrol (Land)"><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F28 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000F28 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:15372591 |texte= Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:15372591" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |